BCTX
NASDAQ · Biotechnology
Briacell Therapeutics Corp
$3.44
+0.00 (+0.00%)
Open$3.49
Previous Close$3.44
Day High$3.49
Day Low$3.36
52W High$20.40
52W Low$3.68
Volume—
Avg Volume3.4K
Market Cap41.24M
P/E Ratio—
EPS$-17.14
SectorBiotechnology
Analyst Ratings
Strong Buy
5 analysts
Price Target
+619.5% upside
Current
$3.44
$3.44
Target
$24.75
$24.75
$18.09
$24.75 avg
$34.06
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 6.36M | 5.82M | 6.86M |
| Net Income | -563,828 | -513,311 | -545,732 |
| Profit Margin | -8.9% | -8.8% | -8.0% |
| EBITDA | -665,396 | -604,117 | -725,268 |
| Free Cash Flow | -534,078 | -494,442 | -500,696 |
| Rev Growth | -7.7% | -7.5% | +13.8% |
| Debt/Equity | 0.28 | 0.30 | 0.25 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $249.46 | -0.54% | 70.2 | 443.23B |
| AMGN | Amgen Inc | $415.21 | -0.63% | 25.8 | 225.90B |
| GILD | Gilead Sciences Inc | $138.36 | +0.16% | — | 169.87B |
| VRTX | Vertex Pharmaceuticals Inc | $505.75 | -2.07% | 30.7 | 135.24B |
| REGN | Regeneron Pharmaceuticals | $803.48 | -0.31% | 19.0 | 82.16B |
| ALNY | Alnylam Pharmaceuticals Inc | $228.65 | +0.67% | 37.6 | 30.39B |